The U.S. government will pay Moderna $176 million to develop an mRNA vaccine for the H5N1 virus, utilizing the same technology as the COVID-19 vaccines.
Moderna is already in early testing stages with supplementary support from the U.S. Department of Health and Human Services through BARDA.
Lessons from COVID-19 are being applied to prepare for future health crises by developing new vaccines such as for influenza, with a focus on pandemic response capabilities.
[
add
]
[
|
|
...
]